Company / Current Liabilities per Share
TG Therapeutics, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.99
FY2025
5-year range
$0.37 / $0.99
FY2021-FY2025
Trend
+64.8%
vs FY2024
Sector context
#115 of 210
Health Care
What the data says
At $0.99, TG Therapeutics, Inc.'s current liabilities per share ranks #96 of 210 in the Health Care sector. Increased from $0.37 to $0.99 over the past 2 years.
Based on SEC 10-K filings.
0.99 in FY2025 with a 5-year CAGR of +4.3%.
Increased from $0.37 to $0.99 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +38.5%
- 5-Year CAGR
- +4.3%
- 10-Year CAGR
- -
Sector benchmark
#96 of 210 in Health CareTop 45% of 210This company $0.99 Sector average $23.79
▼
-95.9% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 64.8% year-over-year.
- Ranks #115 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2019.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.99 | +64.8% |
| FY2024 | $0.60 | +63.2% |
| FY2023 | $0.37 | -1.2% |
| FY2022 | $0.37 | -20.2% |
| FY2021 | $0.47 | -41.9% |
| FY2020 | $0.80 | -20.5% |
| FY2019 | $1.01 | +89.5% |
| FY2018 | $0.53 | +17.9% |
| FY2017 | $0.45 | +30.9% |
| FY2016 | $0.34 | +49.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026